Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression.

Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis. 2010 Dec; 69(12):2152-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.